SCHEDULE OF NET INCOME PER SHARE RECONCILIATION (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net income attributable to China Biologic Products, Inc.	$ 16,161,926	$ 12,838,771	$ 31,077,786	$ 25,796,077
Earnings allocated to participating nonvested shares	(85,227)	0	(157,615)	0
Net income allocated to common stockholders used in computing basic net income per common stock	16,076,699	12,838,771	30,920,171	25,796,077
Change in fair value of warrants	0	(559,758)	0	(1,769,140)
Net income used in diluted net income per common stock	$ 16,076,699	$ 12,279,013	$ 30,920,171	$ 24,026,937